Recent studies provide several practice-relevant insights for dermatologists:

Br J Dermatol. 2025 Sep 18;193(4):696-705. http://doi.org/10.1093/bjd/ljaf214.
Mechanistic in vivo studies of secondary skin-to-skin peanut allergen transfer to determine the impact of hand washing in reducing the risk of cutaneous sensitization.
Baber C, Busch L, Klein AL, Infante VHP, Abdul-Jabbar S, Benaouda F, Khurana P, Jones SA, Novak N, Santos AF, Flohr C, Meinke MC, Lohan SB

J Am Acad Dermatol. 2025 Dec;93(6):1471-1480. http://doi.org/10.1016/j.jaad.2025.08.020.
Decreased risk of reduced linear growth among children with atopic dermatitis receiving dupilumab: A cohort study.
Chen TL, Ma SH, Ou WF, Chen CC, Wu CY

J Am Acad Dermatol. 2025 Dec;93(6):1582-1584. http://doi.org/10.1016/j.jaad.2025.08.017.
Sustained remission of guttate psoriasis flares with short-term interleukin-23 inhibition: A case series.
Hodelin C, Xie CB, Katini S, Johnston MS, Cohen JM

Dermatol Surg. 2025 Aug 6. http://doi.org/10.1097/DSS.0000000000004784
The Use of Perioperative Cephalexin in Penicillin Allergic Patients in Dermatologic Surgery: An Advisory Statement
Campbell E, Virk A, Gonzalez-Estrada A, Lessard S, Otley C

Dermatitis. 2025 Aug 6. http://doi.org/10.1177/17103568251365630
Review of Fixed Food Eruptions.
Gratz BW, Garg KS, Raja AR, Hussain A

Br J Dermatol. 2025 Oct 17;193(5):865–875. http://doi.org/10.1093/bjd/ljaf303
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial.
Becker JC, Gesierich AH, Leiter U, Zimmer L, Hassel JC, von Wasielewski I, Ziemer M, Fluck M, Meier F, Spillner AN, Schilling B, Eigentler TK, Livingstone E, Ugurel S, Angela Y, Windemuth-Kieselbach C, Gutzmer R